Human platelet alloantigen typing: PCR analysis is not a substitute for serological methods

Area of Science:

• Immunogenetics
• Molecular Biology
• Hematology

Background:

• Five human platelet antigen (HPA) systems are established, with HPA-1, -3, and -4 located on the glycoprotein (GP) IIb-IIIa complex.
• Polymorphisms in GP IIb and GP IIIa genes, caused by single nucleotide substitutions, form the basis of HPA systems.
• Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) enables HPA typing by detecting these genetic variations.

Purpose of the Study:

• To validate PCR-RFLP as a method for platelet antigen typing.
• To compare the accuracy of PCR-RFLP with the monoclonal-antibody-specific immobilization of platelet antigens (MAIPA) assay.
• To investigate discrepancies between molecular and serological methods in identifying HPA systems.

Main Methods:

• Utilized PCR-RFLP to analyze DNA for HPA typing.
• Employed MAIPA assay for serological HPA typing.
• Studied Glanzmann thrombasthenic families, including heterozygous individuals, to identify discrepancies.

Main Results:

• Identified discrepancies between PCR-RFLP and MAIPA in two families, indicating a lack of antigen expression on the platelet surface.
• Observed a lack of correlation between molecular and serological methods in HPA-1 and HPA-3 systems.
• Highlighted potential interference from unknown molecular defects affecting PCR results.

Conclusions:

• PCR-RFLP and MAIPA may not always yield concordant results for platelet antigen typing.
• Unknown molecular defects can lead to false-positive or false-negative results in PCR-based HPA typing.
• Further investigation is needed to understand the discrepancies between molecular and serological HPA typing methods.